Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation

J Biol Chem. 1999 Oct 22;274(43):30419-23. doi: 10.1074/jbc.274.43.30419.

Abstract

Glycogen synthase kinase-3 (GSK) can be regulated by different signaling pathways including those mediated by protein kinase Akt and Wnt proteins. Wnt proteins are believed to activate a transcription factor leukemia enhancer factor-1 (LEF-1) by inhibiting GSK, and Akt was shown to phosphorylate GSK and inhibit its kinase activity. We investigated the effect of an activated Akt on the accumulation of cytosolic beta-catenin and LEF-1-dependent transcription. Although the activated Akt, mAkt, clearly inhibited the kinase activity of GSK, mAkt alone did not induce accumulation of cytosolic beta-catenin or activate LEF-1-dependent transcription. On the contrary, coexpressed Wnt-1 and Frat activated LEF-1 but did not show significant inhibition of GSK-mediated phosphorylation of a peptide substrate. However, mAkt could act synergistically with Wnt-1 or Frat to activate LEF-1. In addition, the interaction of GSK for Axin appeared to decrease in the presence of mAkt, whereas the interaction for Frat remained unchanged. Consistently, a GSK mutant with substitution of a Phe residue for residue Tyr-216, which showed one-fifth of kinase activity of the wild-type GSK, exhibited a reduced association for Axin than the wild-type GSK. These results suggest that inhibition of GSK kinase activity is not sufficient for activation of LEF-1 but may facilitate the activation by reducing the interaction of GSK for Axin. The additional mechanism for LEF-1 activation may require dissociation of GSK from Axin as Frat facilitates the dissociation of GSK from Axin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3T3 Cells
  • Adaptor Proteins, Signal Transducing
  • Animals
  • Axin Protein
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Carrier Proteins*
  • Cytoskeletal Proteins / metabolism
  • DNA-Binding Proteins / metabolism*
  • Enzyme Activation
  • Genes, Reporter
  • Glycogen Synthase Kinase 3
  • Glycogen Synthase Kinases
  • Luciferases / genetics
  • Luciferases / metabolism
  • Lymphoid Enhancer-Binding Factor 1
  • Mice
  • Neoplasm Proteins*
  • Phosphorylation
  • Protein Serine-Threonine Kinases*
  • Protein-Tyrosine Kinases / metabolism
  • Proteins / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • Recombinant Proteins / biosynthesis
  • Repressor Proteins*
  • Signal Transduction
  • Trans-Activators*
  • Transcription Factors / metabolism*
  • Transcription, Genetic*
  • Transfection
  • Wnt Proteins
  • Wnt1 Protein
  • Zebrafish Proteins*
  • beta Catenin

Substances

  • Adaptor Proteins, Signal Transducing
  • Axin Protein
  • CTNNB1 protein, mouse
  • Carrier Proteins
  • Cytoskeletal Proteins
  • DNA-Binding Proteins
  • Frat1 protein, mouse
  • Lef1 protein, mouse
  • Lymphoid Enhancer-Binding Factor 1
  • Neoplasm Proteins
  • Proteins
  • Proto-Oncogene Proteins
  • Recombinant Proteins
  • Repressor Proteins
  • Trans-Activators
  • Transcription Factors
  • Wnt Proteins
  • Wnt1 Protein
  • Wnt1 protein, mouse
  • Zebrafish Proteins
  • beta Catenin
  • Luciferases
  • Protein-Tyrosine Kinases
  • Glycogen Synthase Kinases
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Glycogen Synthase Kinase 3